Prior Information Notice (PIN) for an innovation partnership to develop Artificial Intelligence (AI) in mammography

The Royal Marsden NHS Foundation Trust (RM), working as part of a RM Partners (cancer alliance for north west and south west London) funded programme is seeking to create an innovation partnership to support a clinical research evaluation of an Artificial Intelligence (AI) tool developed for diagnosis of breast cancer on mammography images acquired in breast screening, in a retrospective study of use on images acquired in the symptomatic breast clinic. <br/><br/>This procurement is to partner with an AI vendor to demonstrate performance of their AI tool developed for use in breast screening, in the context of the symptomatic breast clinic, using retrospective data. <br/><br/>This project hypothesis is that an AI tool developed for use in breast screening could be useful in the context of symptomatic breast clinics. However, these systems developed in the screening setting have unknown performance in the context of symptomatic breast clinic. It is therefore important to test the performance of these systems in this alternative setting. <br/><br/>This work will be carried out in collaboration with the selected AI vendor and clinical teams from participating sites providing retrospective data to define optimal use case scenarios for the symptomatic breast clinic. <br/><br/>This project is funded by RM Partners, the cancer alliance for north west and south west London for 18 months and research ethics submission for a multi-centre, retrospective, diagnostic accuracy study is underway. <br/><br/>The Authority is seeking to engage the market to further explore and define the technical and commercial delivery models that would underpin the partnership. <br/><br/>Further information, including details of how to submit an expression of interest as part of Pre-Market Engagement, can be found at the end of this Notice.